Influences of biofluid sample collection and handling procedures on GC-MS based metabolomic studies

Kiyoko Bando, Rui Kawahara, Takeshi Kunimatsu, Jun Sakai, Juki Kimura, Hitoshi Funabashi, Takaki Seki, Takeshi Bamba, Eiichiro Fukusaki

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Sample collection procedures of pharmacology and toxicology studies might have a great impact on interpretation of metabolomic study results. Characterization of range variation among sample collection methods is necessary to prevent misinterpretation, as is use of optimal methods in animal experiments to minimize biological/technical variation. Here, we investigated the influence of urine and plasma sample collection and handling procedures on GC-MS based metabolomic studies as follows: for urine, pooling period and tube conditions during collection; for plasma, sampling sites, anesthesia and anticoagulants. Metabolic profiles of urine varied dramatically depending on urine pooling period and tube conditions, underscoring the importance of determining appropriate sampling periods in consideration of diurnal effects and targets of effect/toxicity, and suggesting it would be preferable to keep tubes in metabolic cages under iced conditions for urine sampling. Metabolic profiles of plasma differed depending on blood sampling sites. Anesthesia was not effective in reducing individual variation, although the anesthesia was beneficial in reducing discomfort in rats. In GC-MS based metabolomic studies, we recommend that EDTA be used as anticoagulant in plasma sample preparation, because peaks derived from heparin might overlap with endogenous metabolites, which may induce inter-sample variation. The present study demonstrated that biofluid sample collection and handling procedures provide great impact on metabolic profiles, at the very least for minimizing biological/technical variation, sampling period for urine collection should not be set as a short period, and the use of EDTA is recommended as anticoagulant in preparing plasma for analysis by GC-MS.

Original languageEnglish
Pages (from-to)491-499
Number of pages9
JournalJournal of Bioscience and Bioengineering
Volume110
Issue number4
DOIs
Publication statusPublished - Oct 1 2010
Externally publishedYes

Fingerprint

Metabolomics
Urine
Metabolome
Sampling
Plasmas
Anticoagulants
Anesthesia
Ethylenediaminetetraacetic acid
Edetic Acid
Urine Specimen Collection
Metabolites
Toxicology
Toxicity
Heparin
Rats
Animals
Blood
Pharmacology
Experiments

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology

Cite this

Bando, K., Kawahara, R., Kunimatsu, T., Sakai, J., Kimura, J., Funabashi, H., ... Fukusaki, E. (2010). Influences of biofluid sample collection and handling procedures on GC-MS based metabolomic studies. Journal of Bioscience and Bioengineering, 110(4), 491-499. https://doi.org/10.1016/j.jbiosc.2010.04.010

Influences of biofluid sample collection and handling procedures on GC-MS based metabolomic studies. / Bando, Kiyoko; Kawahara, Rui; Kunimatsu, Takeshi; Sakai, Jun; Kimura, Juki; Funabashi, Hitoshi; Seki, Takaki; Bamba, Takeshi; Fukusaki, Eiichiro.

In: Journal of Bioscience and Bioengineering, Vol. 110, No. 4, 01.10.2010, p. 491-499.

Research output: Contribution to journalArticle

Bando, K, Kawahara, R, Kunimatsu, T, Sakai, J, Kimura, J, Funabashi, H, Seki, T, Bamba, T & Fukusaki, E 2010, 'Influences of biofluid sample collection and handling procedures on GC-MS based metabolomic studies', Journal of Bioscience and Bioengineering, vol. 110, no. 4, pp. 491-499. https://doi.org/10.1016/j.jbiosc.2010.04.010
Bando, Kiyoko ; Kawahara, Rui ; Kunimatsu, Takeshi ; Sakai, Jun ; Kimura, Juki ; Funabashi, Hitoshi ; Seki, Takaki ; Bamba, Takeshi ; Fukusaki, Eiichiro. / Influences of biofluid sample collection and handling procedures on GC-MS based metabolomic studies. In: Journal of Bioscience and Bioengineering. 2010 ; Vol. 110, No. 4. pp. 491-499.
@article{18c15048f81e4c1e89dd92a0b32ecfec,
title = "Influences of biofluid sample collection and handling procedures on GC-MS based metabolomic studies",
abstract = "Sample collection procedures of pharmacology and toxicology studies might have a great impact on interpretation of metabolomic study results. Characterization of range variation among sample collection methods is necessary to prevent misinterpretation, as is use of optimal methods in animal experiments to minimize biological/technical variation. Here, we investigated the influence of urine and plasma sample collection and handling procedures on GC-MS based metabolomic studies as follows: for urine, pooling period and tube conditions during collection; for plasma, sampling sites, anesthesia and anticoagulants. Metabolic profiles of urine varied dramatically depending on urine pooling period and tube conditions, underscoring the importance of determining appropriate sampling periods in consideration of diurnal effects and targets of effect/toxicity, and suggesting it would be preferable to keep tubes in metabolic cages under iced conditions for urine sampling. Metabolic profiles of plasma differed depending on blood sampling sites. Anesthesia was not effective in reducing individual variation, although the anesthesia was beneficial in reducing discomfort in rats. In GC-MS based metabolomic studies, we recommend that EDTA be used as anticoagulant in plasma sample preparation, because peaks derived from heparin might overlap with endogenous metabolites, which may induce inter-sample variation. The present study demonstrated that biofluid sample collection and handling procedures provide great impact on metabolic profiles, at the very least for minimizing biological/technical variation, sampling period for urine collection should not be set as a short period, and the use of EDTA is recommended as anticoagulant in preparing plasma for analysis by GC-MS.",
author = "Kiyoko Bando and Rui Kawahara and Takeshi Kunimatsu and Jun Sakai and Juki Kimura and Hitoshi Funabashi and Takaki Seki and Takeshi Bamba and Eiichiro Fukusaki",
year = "2010",
month = "10",
day = "1",
doi = "10.1016/j.jbiosc.2010.04.010",
language = "English",
volume = "110",
pages = "491--499",
journal = "Journal of Bioscience and Bioengineering",
issn = "1389-1723",
publisher = "The Society for Biotechnology, Japan",
number = "4",

}

TY - JOUR

T1 - Influences of biofluid sample collection and handling procedures on GC-MS based metabolomic studies

AU - Bando, Kiyoko

AU - Kawahara, Rui

AU - Kunimatsu, Takeshi

AU - Sakai, Jun

AU - Kimura, Juki

AU - Funabashi, Hitoshi

AU - Seki, Takaki

AU - Bamba, Takeshi

AU - Fukusaki, Eiichiro

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Sample collection procedures of pharmacology and toxicology studies might have a great impact on interpretation of metabolomic study results. Characterization of range variation among sample collection methods is necessary to prevent misinterpretation, as is use of optimal methods in animal experiments to minimize biological/technical variation. Here, we investigated the influence of urine and plasma sample collection and handling procedures on GC-MS based metabolomic studies as follows: for urine, pooling period and tube conditions during collection; for plasma, sampling sites, anesthesia and anticoagulants. Metabolic profiles of urine varied dramatically depending on urine pooling period and tube conditions, underscoring the importance of determining appropriate sampling periods in consideration of diurnal effects and targets of effect/toxicity, and suggesting it would be preferable to keep tubes in metabolic cages under iced conditions for urine sampling. Metabolic profiles of plasma differed depending on blood sampling sites. Anesthesia was not effective in reducing individual variation, although the anesthesia was beneficial in reducing discomfort in rats. In GC-MS based metabolomic studies, we recommend that EDTA be used as anticoagulant in plasma sample preparation, because peaks derived from heparin might overlap with endogenous metabolites, which may induce inter-sample variation. The present study demonstrated that biofluid sample collection and handling procedures provide great impact on metabolic profiles, at the very least for minimizing biological/technical variation, sampling period for urine collection should not be set as a short period, and the use of EDTA is recommended as anticoagulant in preparing plasma for analysis by GC-MS.

AB - Sample collection procedures of pharmacology and toxicology studies might have a great impact on interpretation of metabolomic study results. Characterization of range variation among sample collection methods is necessary to prevent misinterpretation, as is use of optimal methods in animal experiments to minimize biological/technical variation. Here, we investigated the influence of urine and plasma sample collection and handling procedures on GC-MS based metabolomic studies as follows: for urine, pooling period and tube conditions during collection; for plasma, sampling sites, anesthesia and anticoagulants. Metabolic profiles of urine varied dramatically depending on urine pooling period and tube conditions, underscoring the importance of determining appropriate sampling periods in consideration of diurnal effects and targets of effect/toxicity, and suggesting it would be preferable to keep tubes in metabolic cages under iced conditions for urine sampling. Metabolic profiles of plasma differed depending on blood sampling sites. Anesthesia was not effective in reducing individual variation, although the anesthesia was beneficial in reducing discomfort in rats. In GC-MS based metabolomic studies, we recommend that EDTA be used as anticoagulant in plasma sample preparation, because peaks derived from heparin might overlap with endogenous metabolites, which may induce inter-sample variation. The present study demonstrated that biofluid sample collection and handling procedures provide great impact on metabolic profiles, at the very least for minimizing biological/technical variation, sampling period for urine collection should not be set as a short period, and the use of EDTA is recommended as anticoagulant in preparing plasma for analysis by GC-MS.

UR - http://www.scopus.com/inward/record.url?scp=77956650455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956650455&partnerID=8YFLogxK

U2 - 10.1016/j.jbiosc.2010.04.010

DO - 10.1016/j.jbiosc.2010.04.010

M3 - Article

C2 - 20547363

AN - SCOPUS:77956650455

VL - 110

SP - 491

EP - 499

JO - Journal of Bioscience and Bioengineering

JF - Journal of Bioscience and Bioengineering

SN - 1389-1723

IS - 4

ER -